Elasty F Plus (2 Syringes)

ELASTY F plus 2 syringes

Within its category, ELASTY F plus 2 syringes has a straightforward role: fine-line refinement, elasticity support, and deeper-fold correction. Its balanced deep-correction profile and hyaluronic acid and cross-linked hyaluronic acid formulation give practitioners a clearer basis for deciding when it fits, and when a neighbouring variant may be the better choice.

Where This Product Fits

For a professional buyer, the deciding points are concrete. ELASTY F plus 2 syringes should be assessed through its material profile, intended objective and exact presentation.

• Formulation focus: cross-linked hyaluronic acid and lidocaine
• Main professional objectives: fine-line refinement, elasticity support, deeper-fold correction, and volume restoration
• Most relevant treatment areas: forehead lines, lips and perioral area, neck, jawline or masseter area, and chin
• Presentation details: 24mg/ml

1. Filler and Gel Profile

ELASTY F plus 2 syringes is positioned as a balanced-to-structured profile for deeper folds, contour definition and moderate volume correction. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. How the Gel Supports Correction

ELASTY F plus 2 syringes is designed to provide physical support within professionally selected tissue planes. Its practical behaviour is linked to the gel profile: softer variants favour integration and refinement, while more structured variants are selected when projection, contour definition or volume replacement is the priority. This named variant balances correction and support according to its product profile.

3. Main Correction Goals

• Facial contour refinement
• Volume restoration
• Structural projection
• Deep-fold correction

4. Facial Areas Suited to This Profile

ELASTY F plus 2 syringes is commonly associated with:

• Jawline and masseter area
• Chin
• Lips and perioral area
• Cheeks and midface
• Nasolabial folds
• Marionette lines

For ELASTY F plus 2 syringes, area selection, quantity and technique remain part of the practitioner’s product-specific plan.

5. Formulation and Syringe Specifications

The formulation includes cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride. The sealed label for ELASTY F plus 2 syringes remains the controlling reference for its exact ingredient statement.

• Product: ELASTY F plus 2 syringes
• Product type: Professional injectable dermal filler
• ELASTY F plus 2 syringes: Variant profile: A balanced-to-structured profile for deeper folds, contour definition and moderate volume correction
• Reported strength or volume: 1.0ml, 24mg/ml, 1ml, and 24 mg/ml
• ELASTY F plus 2 syringes: Reported formulation: cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride
• Package details: 2 syringes, 1 Syringe, 1.0ml, and 1ml
• ELASTY F plus 2 syringes: Storage profile: do not freeze, protect from direct light, and room-temperature storage is mentioned

6. Expected Integration and Result Profile

For ELASTY F plus 2 syringes, the visible profile is linked to the selected correction goal. Integration, projection and contour support should be assessed according to the named gel variant, treatment plane, area and quantity used rather than applying one duration claim to the entire product family.

7. Package and Storage Information

For this presentation, the reported package presentation includes 2 syringes, 1 Syringe, 1.0ml, and 1ml. The available product information specifies do not freeze, protect from direct light, and room-temperature storage is mentioned. The sealed outer box and current instructions remain the controlling handling reference.

9. Frequently Asked Questions

What is ELASTY F plus 2 syringes?

For ELASTY F plus 2 syringes, the product is a professional injectable dermal filler positioned as a balanced-to-structured profile for deeper folds, contour definition and moderate volume correction. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of ELASTY F plus 2 syringes?

For ELASTY F plus 2 syringes, for this formulation, its product profile centres on facial contour refinement, volume restoration, structural projection, and deep-fold correction. The final treatment objective and technique are selected by a qualified professional.

What does ELASTY F plus 2 syringes contain?

For ELASTY F plus 2 syringes, for this presentation, available product information describes cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride.

Which areas are associated with ELASTY F plus 2 syringes?

For ELASTY F plus 2 syringes, the product information associates the named variant with jawline and masseter area, chin, lips and perioral area, cheeks and midface, nasolabial folds, and marionette lines. Suitability and placement depend on the exact product instructions and individual assessment.

How is ELASTY F plus 2 syringes supplied?

this formulation is described with 2 syringes, 1 Syringe, 1.0ml, and 1ml. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For ELASTY F plus 2 syringes, the product should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. the product is positioned as a balanced-to-structured profile for deeper folds, contour definition and moderate volume correction.

10. Professional Use

Manufacturer-Confirmed Details

For this formulation, dongbang Medical identifies ELASTY as a Korean hyaluronic-acid filler family built around three physical-property profiles using its PNET technology. The official material supports the family identity and professional wrinkle/volume-correction role. Exact HA concentration, lidocaine status, syringe count and supplied needle must be taken from the named variant’s IFU or carton.